Skip to main content
Erschienen in: Heart and Vessels 5/2015

01.09.2015 | Original Article

Decreased tricuspid regurgitation following percutaneous closure of congenital perimembranous ventricular septal defect: immediate and 6-month echocardiographic assessment

verfasst von: Xu-Dong Xu, Su-Xuan Liu, Yuan Bai, Min Zhang, Xian-Xian Zhao, Yong-Wen Qin

Erschienen in: Heart and Vessels | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

As a common concomitant performance and the most frequent complications of transcatheter perimembranous ventricular septal defect (VSD) closure, tricuspid regurgitation (TR) has rarely been concerned. From January 2008 to December 2012, a total of 70 patients (men: 33, women: 37; mean age: 30.0 ± 17.1 years) with at least mild TR before VSD closure were examined in 508 consecutive congenital perimembranous VSD patients to investigate the outcomes of TR. After VSD closure, the jet area decreased from 3.4 ± 2.5 to 1.2 ± 2.5 cm2 (p < 0.001); however, no significant decrease was found in 3 patients (mean age 59.7 ± 2.5 years) with severe TR (12.0 ± 1.2 versus 11.2 ± 3.2 cm2, p = 0.668). Compared to the early outcome after VSD closure, the jet area detected by TTE at 6-month follow-up had further decreased (1.2 ± 2.5 versus 0.9 ± 2.2 cm2, p < 0.001). In 6 patients, a slight residual shunt was detected immediately after VSD closure and diminished in 3 patients at 6-month follow-up. The hemolysis occurred in one of these six patients and recovered after 3 days. In conclusion, functional TR was ameliorated after percutaneous VSD closure, although persistent abundant TR was common in patients with severe TR before procedure.
Literatur
1.
Zurück zum Zitat Roguin N, Du ZD, Barak M, Nasser N, Hershkowitz S, Milgram E (1995) High prevalence of muscular ventricular septal defect in neonates. J Am Coll Cardiol 26:1545–1548CrossRefPubMed Roguin N, Du ZD, Barak M, Nasser N, Hershkowitz S, Milgram E (1995) High prevalence of muscular ventricular septal defect in neonates. J Am Coll Cardiol 26:1545–1548CrossRefPubMed
2.
Zurück zum Zitat Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900CrossRefPubMed Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900CrossRefPubMed
3.
Zurück zum Zitat Lock JE, Block PC, McKay RG, Baim DS, Keane JF (1988) Transcatheter closure of ventricular septal defects. Circulation 78:361–368CrossRefPubMed Lock JE, Block PC, McKay RG, Baim DS, Keane JF (1988) Transcatheter closure of ventricular septal defects. Circulation 78:361–368CrossRefPubMed
4.
Zurück zum Zitat Carminati M, Butera G, Chessa M, De Giovanni J, Fisher G, Gewillig M, Peuster M, Piechaud JF, Santoro G, Sievert H, Spadoni I, Walsh K (2007) Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J 28:2361–2368CrossRefPubMed Carminati M, Butera G, Chessa M, De Giovanni J, Fisher G, Gewillig M, Peuster M, Piechaud JF, Santoro G, Sievert H, Spadoni I, Walsh K (2007) Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J 28:2361–2368CrossRefPubMed
5.
Zurück zum Zitat Qin Y, Chen J, Zhao X, Liao D, Mu R, Wang S, Wu H, Guo H (2008) Transcatheter closure of perimembranous ventricular septal defect using a modified double-disk occluder. Am J Cardiol 101:1781–1786CrossRefPubMed Qin Y, Chen J, Zhao X, Liao D, Mu R, Wang S, Wu H, Guo H (2008) Transcatheter closure of perimembranous ventricular septal defect using a modified double-disk occluder. Am J Cardiol 101:1781–1786CrossRefPubMed
6.
Zurück zum Zitat Amin Z, Cao QL, Hijazi ZM (2008) Closure of muscular ventricular septal defects: transcatheter and hybrid techniques. Catheter Cardiovasc Interv 72:102–111PubMed Amin Z, Cao QL, Hijazi ZM (2008) Closure of muscular ventricular septal defects: transcatheter and hybrid techniques. Catheter Cardiovasc Interv 72:102–111PubMed
7.
Zurück zum Zitat Gu MB, Bai Y, Zhao XX, Zheng X, Li WP, Qin YW (2009) Transcatheter closure of postoperative residual perimembranous ventricular septal defects. Ann Thorac Surg 88:1551–1555CrossRefPubMed Gu MB, Bai Y, Zhao XX, Zheng X, Li WP, Qin YW (2009) Transcatheter closure of postoperative residual perimembranous ventricular septal defects. Ann Thorac Surg 88:1551–1555CrossRefPubMed
8.
Zurück zum Zitat Thiele H, Kaulfersch C, Daehnert I, Schoenauer M, Eitel I, Borger M, Schuler G (2009) Immediate primary transcatheter closure of postinfarction ventricular septal defects. Eur Heart J 30:81–88CrossRefPubMed Thiele H, Kaulfersch C, Daehnert I, Schoenauer M, Eitel I, Borger M, Schuler G (2009) Immediate primary transcatheter closure of postinfarction ventricular septal defects. Eur Heart J 30:81–88CrossRefPubMed
9.
Zurück zum Zitat Yang J, Yang L, Wan Y, Zuo J, Zhang J, Chen W, Li J, Sun L, Yu S, Liu J, Chen T, Duan W, Xiong L, Yi D (2010) Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes. Eur Heart J 31:2238–2245CrossRefPubMedCentralPubMed Yang J, Yang L, Wan Y, Zuo J, Zhang J, Chen W, Li J, Sun L, Yu S, Liu J, Chen T, Duan W, Xiong L, Yi D (2010) Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes. Eur Heart J 31:2238–2245CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat Gu M, You X, Zhao X, Zheng X, Qin YW (2011) Transcatheter device closure of intracristal ventricular septal defects. Am J Cardiol 107:110–113CrossRefPubMed Gu M, You X, Zhao X, Zheng X, Qin YW (2011) Transcatheter device closure of intracristal ventricular septal defects. Am J Cardiol 107:110–113CrossRefPubMed
11.
Zurück zum Zitat Zhu XY, Qin YW, Han YL, Zhang DZ, Wang P, Liu YF, Xu YW, Jing QM, Xu K, Gersh BJ, Wang XZ (2013) Long-term efficacy of transcatheter closure of ventricular septal defect in combination with percutaneous coronary intervention in patients with ventricular septal defect complicating acute myocardial infarction: a multicentre study. EuroIntervention 8:1270–1276CrossRefPubMed Zhu XY, Qin YW, Han YL, Zhang DZ, Wang P, Liu YF, Xu YW, Jing QM, Xu K, Gersh BJ, Wang XZ (2013) Long-term efficacy of transcatheter closure of ventricular septal defect in combination with percutaneous coronary intervention in patients with ventricular septal defect complicating acute myocardial infarction: a multicentre study. EuroIntervention 8:1270–1276CrossRefPubMed
12.
Zurück zum Zitat Miyazaki A, Sakaguchi H, Ohuchi H, Yasuda K, Tsujii N, Matsuoka M, Yamamoto T, Yazaki S, Tsuda E, Yamada O (2013) The clinical characteristics of sudden cardiac arrest in asymptomatic patients with congenital heart disease. Heart Vessels. doi:10.1007/s00380-013-0444-9 Miyazaki A, Sakaguchi H, Ohuchi H, Yasuda K, Tsujii N, Matsuoka M, Yamamoto T, Yazaki S, Tsuda E, Yamada O (2013) The clinical characteristics of sudden cardiac arrest in asymptomatic patients with congenital heart disease. Heart Vessels. doi:10.​1007/​s00380-013-0444-9
13.
Zurück zum Zitat Pedra CA, Pedra SR, Esteves CA, Pontes SC Jr, Braga SL, Arrieta SR, Santana MV, Fontes VF, Masura J (2004) Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: technical and morphological considerations. Catheter Cardiovasc Interv 61:403–410CrossRefPubMed Pedra CA, Pedra SR, Esteves CA, Pontes SC Jr, Braga SL, Arrieta SR, Santana MV, Fontes VF, Masura J (2004) Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: technical and morphological considerations. Catheter Cardiovasc Interv 61:403–410CrossRefPubMed
14.
Zurück zum Zitat Li P, Zhao XX, Zheng X, Qin YW (2012) Arrhythmias after transcatheter closure of perimembranous ventricular septal defects with a modified double-disk occluder: early and long-term results. Heart Vessels 27:405–410CrossRefPubMed Li P, Zhao XX, Zheng X, Qin YW (2012) Arrhythmias after transcatheter closure of perimembranous ventricular septal defects with a modified double-disk occluder: early and long-term results. Heart Vessels 27:405–410CrossRefPubMed
15.
Zurück zum Zitat Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group, American Society of Echocardiography’s Guidelines and Standards Committee, European Association of Echocardiography (2005) Recommendations for chamber quantification: a report from the American society of echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group, American Society of Echocardiography’s Guidelines and Standards Committee, European Association of Echocardiography (2005) Recommendations for chamber quantification: a report from the American society of echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed
16.
Zurück zum Zitat Hatle L (1981) Noninvasive assessment and differentiation of left ventricular outflow obstruction with Doppler ultrasound. Circulation 64:381–387CrossRefPubMed Hatle L (1981) Noninvasive assessment and differentiation of left ventricular outflow obstruction with Doppler ultrasound. Circulation 64:381–387CrossRefPubMed
17.
Zurück zum Zitat Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ (2003) Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16:777–802CrossRefPubMed Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ (2003) Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16:777–802CrossRefPubMed
18.
Zurück zum Zitat Chopra HK, Nanda NC, Fan P, Kapur KK, Goyal R, Daruwalla D, Pacifico A (1989) Can two-dimensional echocardiography and Doppler color flow mapping identify the need for tricuspid valve repair? J Am Coll Cardiol 14:1266–1274CrossRefPubMed Chopra HK, Nanda NC, Fan P, Kapur KK, Goyal R, Daruwalla D, Pacifico A (1989) Can two-dimensional echocardiography and Doppler color flow mapping identify the need for tricuspid valve repair? J Am Coll Cardiol 14:1266–1274CrossRefPubMed
19.
Zurück zum Zitat Sagie A, Schwammenthal E, Padial LR, Vazquez de Prada JA, Weyman AE, Levine RA (1994) Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: doppler color flow study of 109 patients. J Am Coll Cardiol 24:446–453CrossRefPubMed Sagie A, Schwammenthal E, Padial LR, Vazquez de Prada JA, Weyman AE, Levine RA (1994) Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: doppler color flow study of 109 patients. J Am Coll Cardiol 24:446–453CrossRefPubMed
20.
Zurück zum Zitat Hinderliter AL, Willis PW, Long WA, Clarke WR, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Boisblanc B, Koch G, Li S, Clayton LM, Jöbsis MM, Crow JW, PPH Study Group (2003) Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension. Am J Cardiol 91(1033–1037):A9 Hinderliter AL, Willis PW, Long WA, Clarke WR, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Boisblanc B, Koch G, Li S, Clayton LM, Jöbsis MM, Crow JW, PPH Study Group (2003) Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension. Am J Cardiol 91(1033–1037):A9
21.
Zurück zum Zitat Fukuda S, Song JM, Gillinov AM, McCarthy PM, Daimon M, Kongsaerepong V, Thomas JD, Shiota T (2005) Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty. Circulation 111:975–979CrossRefPubMed Fukuda S, Song JM, Gillinov AM, McCarthy PM, Daimon M, Kongsaerepong V, Thomas JD, Shiota T (2005) Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty. Circulation 111:975–979CrossRefPubMed
22.
Zurück zum Zitat Rogers JH, Bolling SF (2009) The tricuspid valve: current perspective and evolving management of tricuspid regurgitation. Circulation 119:2718–2725CrossRefPubMed Rogers JH, Bolling SF (2009) The tricuspid valve: current perspective and evolving management of tricuspid regurgitation. Circulation 119:2718–2725CrossRefPubMed
23.
Zurück zum Zitat Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP Jr, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114:e84–e231CrossRefPubMed Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP Jr, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114:e84–e231CrossRefPubMed
24.
Zurück zum Zitat Mutlak D, Aronson D, Lessick J, Reisner SA, Dabbah S, Agmon Y (2009) Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity? Chest 135:115–121CrossRefPubMed Mutlak D, Aronson D, Lessick J, Reisner SA, Dabbah S, Agmon Y (2009) Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity? Chest 135:115–121CrossRefPubMed
25.
Zurück zum Zitat Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF (2002) Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 144:524–529CrossRefPubMed Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF (2002) Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 144:524–529CrossRefPubMed
26.
Zurück zum Zitat Nath J, Foster E, Heidenreich PA (2004) Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 43:405–409CrossRefPubMed Nath J, Foster E, Heidenreich PA (2004) Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 43:405–409CrossRefPubMed
27.
Zurück zum Zitat McCarthy PM, Bhudia SK, Rajeswaran J, Hoercher KJ, Lytle BW, Cosgrove DM, Blackstone EH (2004) Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 127:674–685CrossRefPubMed McCarthy PM, Bhudia SK, Rajeswaran J, Hoercher KJ, Lytle BW, Cosgrove DM, Blackstone EH (2004) Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 127:674–685CrossRefPubMed
Metadaten
Titel
Decreased tricuspid regurgitation following percutaneous closure of congenital perimembranous ventricular septal defect: immediate and 6-month echocardiographic assessment
verfasst von
Xu-Dong Xu
Su-Xuan Liu
Yuan Bai
Min Zhang
Xian-Xian Zhao
Yong-Wen Qin
Publikationsdatum
01.09.2015
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 5/2015
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-014-0531-6

Weitere Artikel der Ausgabe 5/2015

Heart and Vessels 5/2015 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.